Challenges in the treatment of colonic motility disorders

American Journal of Health-System Pharmacy

Volumn 53, Issue 22 SUPPL., 1996, Pages

  Reynolds, James C ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cathartics and laxatives; Cisapride; Colonic diseases; Constipation; Dietary fiber; Gastrointestinal drugs; Gastrointestinal motility; Nutrition

Indexed keywords

CISAPRIDE; LAXATIVE; LEUPRORELIN; MISOPROSTOL; OPIATE DERIVATIVE; PROKINETIC AGENT;

COLON DISEASE; COLON MOTILITY; CONFERENCE PAPER; DIETARY FIBER; HUMAN; INTESTINE PSEUDOOBSTRUCTION; IRRITABLE COLON; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0029852303     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/53.22_suppl_3.s17     Document Type: Conference Paper

References (77)

1. Martelli H, Devroede G, Arhan P et al. Some parameters of large bowel motility in normal man. Gastroenterology. 1978; 75:612-18.
2. Drossman DA, Sandler RS, McKee DC et al. Bowel patterns among subjects not seeking health care: use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology. 1982; 83:529-34.
3. Wyman JB, Heaton KW, Manning AP et al. Variability of colonic function in healthy subjects. Gut. 1978; 19:146-50.
4. Ohe MR, Camilleri M. Measurement of small bowel and coIonic transit: indications and methods. Mayo Clin Proc. 1992; 67:1169-79.
5. Tucker DM, Sandstead HH, Logan GM Jr et al. Dietary fiber and personality factors as determinants of stool output. Gastroenterology. 1981; 81:879-83.
6. Metcalf AM, Phillips SF, Zinsmeister AR et al. Simplified assessment of segmental colonic transit. Gastroenterology. 1987; 92:40-7.
7. Narducci F, Bassotti G, Gaburri M et al. Twenty-five hour manometric recording of colonic motor activity in healthy man. Gut. 1987; 28:17-25.
8. Sullivan MA, Cohen S, Snape WJ Jr. Colonic myoelectrical activity in irritable-bowel syndrome. N Engl J Med. 1978; 298:878-83.
9. Bazzocchi G, Ellis J, Villanueva-Meyer J et al. Postprandial colonic transit and motor activity in chronic constipation. Gastroenterology. 1990; 98:686-93.
10. Krevsky B, Malmud LS, Somers MB et al. Patterns of colonic transit in chronic idiopathic constipation. Gastroenterology. 1986; 90:1503A.
11. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonie motility disorders. Gastroenterology. 1992; 103:36-42.
12. Stivland T, Camilleri M, Vassallo M et al. Scintigraphic measurement of regional gut transit in idiopathic constipation. Gastroenterology. 1991; 101:107-15.
13. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radiopaque markers. Gut. 1969; 10:842-7.
14. Arhan P, Devroede G, Jehannin B et al. Segmental colonic transit time. Dis Colon Rectum. 1981; 24:625-9.
15. Vassallo M, Camilleri M, Phillips SF et al. Transit through the proximal colon influences stool weight in the irritable bowel syndrome. Gastroenterology. 1992; 102:102-8.
16. Read NW, Miles CA, Fisher D et al. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhea. Gastroenterology. 1980; 79:1276-82.
17. Reynolds JC. Motility disorders of the colon. In: Yamada T, ed. Textbook of gastroenterology. Philadelphia: Lippincott; 1991:1715-33.
18. Connell AM. The motility of the pelvic colon (part II). Paradoxical motility in diarrhoea and constipation. Gut. 1962; 3:342-8.
19. Sasaki D, Kido A, Yoshida Y. An endoscopie method to study the relationship between bowel habit and motility of the ascending and sigmoid colon. Gastrointest Endosc. 1986; 32: 185-9.
20. Sarna SK. Physiology and pathophysiology of colonic motor activity (part one of two). Dig Dis Sci. 1991; 36:827-62.
21. Mortensen PB, Andersen JR, Arffmann S et al. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol. 1987; 22:185-92.
22. Read NW. Colon: relationship between epithelial transport and motility. Pharmacology. 1988; 36(Suppl 1):120-5.
23. Loeschke K, Fabritius H, Welter HF. Adaptation of electrolyte transport in rat large intestine after proximal resection. I. Cecum and colon after 60% jejunoilectomy. Pflügers Arch. 1986; 406:323-7.
24. Martelli H, Devroede G, Arhan P et al. Mechanisms of idiopathic constipation: outlet obstruction. Gastroenterology. 1978; 75:623-31.
25. Bartolo DC, Read NW, Jarratt JA et al. Differences in anal sphincter function and clinical presentation in patients with pelvic floor descent. Gastroenterology. 1983; 85:68-75.
26. Preston DM, Lennard-Jones JE. Pelvic motility and response to intraluminal bisacodyl in slow-transit constipation. Dig Dis Sci. 1985; 30:289-94.
27. Watier A, Devroede G, Duranceau A et al. Constipation with colonic inertia: a manifestation of systemic disease? Dig Dis Sci. 1983; 28:1025-33.
28. Battle WM, Snape WJ Jr, Alavi A et al. Colonic dysfunction in diabetes mellitus. Gastroenterology. 1980; 79:1217-21.
29. Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. N Engl J Med. 1984; 310:1282-7.
30. Schuffler MD, Baird HW, Fleming CR et al. Intestinal pseudo-obstruction as the presenting manifestation of small-cell carcinoma of the lung. Ann Intern Med. 1983; 98:129-34.
31. Devroede G, Arhan P, Duguay C et al. Traumatic constipation. Gastroenterology. 1979; 77:1258-67.
32. Glick ME, Meshkinpour H, Haldeman S et al. Colonic dysfunction in multiple sclerosis. Gastroenterology. 1982; 83:1002-7.
33. Hinds JP, Wald A. Colonie and anorectal dysfunction associated with multiple sclerosis. Am J Gastroenterol. 1989; 84:587-95.
34. Battle WM, Snape WJ Jr, Wright S et al. Abnormal colonie motility in progressive systemic sclerosis. Ann Intern Med. 1981; 94:749-52.
35. Pinotti HW, Habr-Gama A, Cecconello I et al. The surgical treatment of megaesophagus and megacolon. Dig Dis Sci. 1993; 11:206-15.
36. Prata A. Chagas' disease. Infect Dis Clin North Am. 1994; 8: 61-76.
37. Vanek VW, Al-Salti M. Acute pseudo-obstruction of the colon (Ogilvie's syndrome). An analysis of 400 cases. Dis Colon Rectum. 1986; 29:203-10.
38. Nanni C, Garbini A, Luchetti P et al. Ogilvie's syndrome (acute chronic pseudo-obstruction): review of the literature (October 1948 to March 1980) and report of four additional cases. Dis Colon Rectum. 1982; 25:157-66.
39. Lynn RB, Friedman LS. Irritable bowel syndrome. N Engl J Med. 1993; 329:1940-5.
40. Whitehead WE, Holtkotter B, Enck P et al. Tolerance of rectosigmoid distention in irritable bowel syndrome. Gastroenterology. 1990; 98:1187-92.
41. Drossman DA, Thompson WG. The irritable bowel syndrome: review and a graduated multicomponent treatment approach. Ann Intern Med. 1992; 116(12 pt 1):1009-16.
42. Leroi A-M, Berkelmans I, Denis P et al. Anismus as a marker of sexual abuse: consequences of abuse on anorectal motility. Dig Dis Sci. 1995; 40:1411-6.
43. Faulk DL, Anuras S, Gardner GD et al. A familial visceral myopathy. Ann Intern Med. 1978; 89(pt 1):600-6.
44. Anuras S, Mitros FA, Nowak TV et al. A familial visceral myopathy with external ophthalmoplegia and autosomal recessive transmission. Gastroenterology. 1983; 84:346-53.
45. Schuffler MD, Bird TD, Sumi SM et al. A familial neuronal disease presenting as intestinal pseudoobstruction. Gastroenterolosy. 1978; 75:889-98.
46. Ahmed MM, Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J. 1975; 113:410-2.
47. Reynolds JC, Ouyang A, Lee CA et al. Chronic severe constipation: prospective motility studies in 25 consecutive patients. Gastroenterology. 1987; 92:414-20.
48. McCready RA, Beart RW Jr. Adult Hirschsprung's disease: results of surgical treatment at Mayo Clinic. Dis Colon Rectum. 1980; 23:401-7.
49. Udassin R, Nissan S, Lernau O et al. The mild form of Hirschsprung's disease (short segment). Ann Surg. 1981; 194:767-70.
50. Todd IP. Adult Hirschsprung's disease. Br J Surg. 1977; 64:311-2.
51. Harrison MW, Dietz DM, Campbell JR et al. Diagnosis and management of Hirschsprung's disease. A 25 year perspective. Am J Surg. 1986; 152:49-56.
52. Madoff RD, Williams JG, Caushaj PF. Fecal incontinence. N Engl J Med. 1992; 326:1002-7.
53. Manning AP, Thompson WG, Heaton KW et al. Towards positive diagnosis of the irritable bowel. Br Med J. 1978; 2:653-4.
54. Drossman DA, Thompson WG, Talley NJ et al. Identification of sub-groups of functional gastrointestinal disorders. Gastroenterol Int. 1990; 3:159-72.
55. Patriquin H, Martelli H, Devroede G. Barium enema in chronic constipation: is it meaningful? Gastroenterology. 1978; 75:619-22.
56. Gekas P, Schuster MM. Stercoral perforation of the colon: case report and review of the literature. Gastroenterology. 1981; 80:1054-8.
57. Ford MJ, Anderson JR, Gilmore HM et al. Clinical spectrum of "solitary ulcer" of the rectum. Gastroenterology. 1983; 84:1533-40.
58. Burkitt DP, Walker ARP, Painter NS. Effect of dietary fibre on stools and transit-times, and its role in the causation of disease. Lancet. 1972; 2:1408-11.
59. Burkitt D. Fiber as protective against gastrointestinal diseases. Gastroenterology. 1984; 79:249-52.
60. Graham DY, Moser SE, Estes MK et al. The effect of bran on bowel function in constipation. Gastroenterology. 1982; 77:599-603.
61. Morehouse JL, Specian RD, Stewart JJ et al. Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment. Gastroenterology. 1986; 91:673-82.
62. Smith B. Effect of irritant purgatives on the myenteric plexus of man and the mouse. Gut. 1968; 9:139-43.
63. Plum GE, Weber HM, Sauer WG. Prolonged cathartic abuse resulting in roentgen evidence suggestive of enterocolitis. Am J Roentgenol Radium Ther Nucl Med. 1960; 83:919-25.
64. Andorsky RI, Goldner F. Colonic lavage solution (polyethylene glycol electrolyte lavage solution) as a treatment for chronic constipation: a double-blind, placebo-controlled study. Am J Gastroenterol. 1990; 85:261-5.
65. Reynolds JC. Prokinetic agents: a key in the future of gastroenterology. Gastroenterol Clin North Am. 1989; 18:437-55.
66. Harrington RA, Hamilton CW, Brogden RN et al. Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs. 1993; 25:451-94.
67. Longo WE, Vernava AM. Prokinetic agents for lower gastrointestinal motility disorders. Dis Colon Rectum. 1993; 36:696-708.
68. Vaz Safatle Ribeiro A, Reynolds JC. Cisapride: mechanisms of action and potential applications. Today's Therapeutic Trends. 1994; 12(1):1-23.
69. Camilleri M, Malagelada J-R, Abell TL et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology. 1989; 96:704-12.
70. Krevsky B, Maurer AH, Malmud LS et al. Cisapride accelerates colonic transit in constipated patients with colonic inertia. Am J Gastroenterol. 1989; 84:882-7.
71. Muller-Lissner SA, The Bavarian Constipation Study Group. Treatment of chronic constipation with cisapride and placebo. Gut. 1987; 28:1033-8.
72. Verheyen K, Vervaeke M, Demyttenaere P et al. Double-blind comparison of two cisapride dosage regimens with placebo in the treatment of functional constipation: a general-practice multicenter study. Curr Ther Res. 1987; 41:978-85.
73. Chapman RW, Sillery J, Fontana DD et al. Effect of oral dioctyl sodium sulfosuccinate on intake-output studies of human small and large intestine. Gastroenterology. 1985; 89:489-93.
74. Mathias JR, Clench MH, Reeves-Darby VG et al. Effect of leuprolide acetate in patients With moderate to severe functional bowel disease: double-blind, placebo-controlled study. Dig Dis Sci. 1994; 39:1155-62.
75. Soffer EE, Metcalf A, Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci. 1994; 39:929-33.
76. Kreek MJ, Hahn EF, Schaefer RA et al. Naloxone: a specific opioid antagonist, reverses chronic idiopathic constipation. Lancet. 1983; 1:261-2.
77. Dapoigny M, Homerin M, Scherrer B et al. Efficacy of fedotozine (F) in the irritable bowel syndrome (IBS): a double-blind placebo-controlled dose-range multicenter study. Gastroenterology. 1993; 104:A495. Abstract.